Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $62.1M | $221.4M | $407.5M | $713.4M | $1,004.6M | $1,794.5M | $2,810.9M | $2,836.3M | $3,012.4M | $3,107.5M | $2,089.9M | $2,314.4M | $2,610.4M | $2,928.7M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Acadia Healthcare Company, Inc.'s last 12-month Revenue is $3,122.5M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Acadia Healthcare Company, Inc.'s Revenue growth was 9.1%. The average annual Revenue growth rates for Acadia Healthcare Company, Inc. have been 5.3% over the past three years, 0.3% over the past five years.
Over the last year, Acadia Healthcare Company, Inc.'s Revenue growth was 9.1%, which is higher than industry growth of 0.2%. It indicates that Acadia Healthcare Company, Inc.'s Revenue growth is Good.